Another important observation from these experiments was that glutamate treatment resulted in a marked increase of phosphorylated tau bearing an AD-relevant epitope (detected by anti-tau pSer396 antibody) (Figures 3D,E). The gene discussed is MAPT; the disease is Alzheimer disease.